Global burden of liver disease: 2023 update
Liver disease accounts for two million deaths annually and is responsible for 4% of all
deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related …
deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related …
[HTML][HTML] The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
The global epidemiology of nonalcoholic fatty liver disease... : Hepatology The global
epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) …
epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) …
Global incidence and prevalence of nonalcoholic fatty liver disease
MLP Teng, CH Ng, DQ Huang, KE Chan… - Clinical and …, 2022 - pmc.ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The
estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among …
estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among …
Randomized, controlled trial of the FGF21 analogue pegozafermin in NASH
Background Pegozafermin is a long-acting glycopegylated (pegylated with the use of site-
specific glycosyltransferases) fibroblast growth factor 21 (FGF21) analogue in development …
specific glycosyltransferases) fibroblast growth factor 21 (FGF21) analogue in development …
[HTML][HTML] Changing epidemiology, global trends and implications for outcomes of NAFLD
Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common liver
disease globally and is currently estimated to affect 38% of the global population. Only a …
disease globally and is currently estimated to affect 38% of the global population. Only a …
Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons
MH Le, DM Le, TC Baez, Y Wu, T Ito, EY Lee… - Journal of …, 2023 - Elsevier
Background & Aims The prevalence of non-alcoholic fatty liver disease (NAFLD) is
increasing. We aimed to estimate the pooled global NAFLD incidence. Methods We …
increasing. We aimed to estimate the pooled global NAFLD incidence. Methods We …
Hepatocellular carcinoma surveillance—Utilization, barriers and the impact of changing aetiology
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …
[HTML][HTML] Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Methods Prevalence data from 245 articles involving 2,699,627 persons were used with a
hierarchical Bayesian approach to forecast the prevalence of NAFLD through 2040 …
hierarchical Bayesian approach to forecast the prevalence of NAFLD through 2040 …
[HTML][HTML] An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease
Alongside the liver, white adipose tissue (WAT) is critical in regulating systemic energy
homeostasis. Although each organ has its specialised functions, they must work …
homeostasis. Although each organ has its specialised functions, they must work …
Exploring the landscape of steatotic liver disease in the general US population
Abstract Background and Objective The aim of the present study is to explore the
epidemiologic impact of the definition of steatotic liver disease (SLD) proposed by a multi …
epidemiologic impact of the definition of steatotic liver disease (SLD) proposed by a multi …